BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33600211)

  • 1. Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas.
    El Sharouni MA; Ahmed T; Varey AHR; Elias SG; Witkamp AJ; Sigurdsson V; Suijkerbuijk KPM; van Diest PJ; Scolyer RA; van Gils CH; Thompson JF; Blokx WAM; Lo SN
    J Clin Oncol; 2021 Apr; 39(11):1243-1252. PubMed ID: 33600211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram.
    Lo SN; Ma J; Scolyer RA; Haydu LE; Stretch JR; Saw RPM; Nieweg OE; Shannon KF; Spillane AJ; Ch'ng S; Mann GJ; Gershenwald JE; Thompson JF; Varey AHR
    J Clin Oncol; 2020 Aug; 38(24):2719-2727. PubMed ID: 32530761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.
    Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Pechoux CL; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Mariani L; Wunder JS; Pollock RE; Casali PG; Gronchi A
    Lancet Oncol; 2016 May; 17(5):671-80. PubMed ID: 27068860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting recurrence in patients with sentinel node-negative melanoma: validation of the EORTC nomogram using population-based data.
    El Sharouni MA; Ahmed T; Witkamp AJ; Sigurdsson V; van Gils CH; Nieweg OE; Scolyer RA; Thompson JF; van Diest PJ; Lo SN
    Br J Surg; 2021 May; 108(5):550-553. PubMed ID: 34043770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation in an Australian population of the EORTC-DeCOG nomogram predicting recurrence, distant metastasis and overall mortality in melanoma patients with positive sentinel lymph nodes.
    Li AT; Law J; Ch'ng S; Scolyer RA; Thompson JF; Lo SN; Varey AHR
    Eur J Cancer; 2023 Aug; 189():112901. PubMed ID: 37263897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a nomogram to predict cancer-specific survival of uveal melanoma.
    Zeng Q; Yao Y; Zhao M
    BMC Ophthalmol; 2021 May; 21(1):230. PubMed ID: 34030647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of risk calculators for people with "thin" melanomas on their skin to predict the likelihood that their cancer will return: a plain language summary of publication.
    Sharouni ME; Lo SN; Varey AH; Elias SG; Witkamp AJ; Sigurdsson V; Suijkerbuijk KP; van Diest PJ; van Gils CH; Blokx WA; Scolyer RA; Thompson JF
    Future Oncol; 2023 Jan; 19(2):97-102. PubMed ID: 36762595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative study.
    Ganly I; Amit M; Kou L; Palmer FL; Migliacci J; Katabi N; Yu C; Kattan MW; Binenbaum Y; Sharma K; Naomi R; Abib A; Miles B; Yang X; Lei D; Bjoerndal K; Godballe C; Mücke T; Wolff KD; Fliss D; Eckardt AM; Chiara C; Sesenna E; Ali S; Czerwonka L; Goldstein DP; Gil Z; Patel SG
    Eur J Cancer; 2015 Dec; 51(18):2768-76. PubMed ID: 26602017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EORTC-DeCOG nomogram adequately predicts outcomes of patients with sentinel node-positive melanoma without the need for completion lymph node dissection.
    Verver D; Rekkas A; Garbe C; van Klaveren D; van Akkooi ACJ; Rutkowski P; Powell BWEM; Robert C; Testori A; van Leeuwen BL; van der Veldt AAM; Keilholz U; Stadler R; Eggermont AMM; Verhoef C; Leiter U; Grünhagen DJ
    Eur J Cancer; 2020 Jul; 134():9-18. PubMed ID: 32454396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and validation of a prognostic nomogram for primary vulvar melanoma: a SEER population-based study.
    Zhou H; Zou X; Li H; Chen L; Cheng X
    Jpn J Clin Oncol; 2020 Dec; 50(12):1386-1394. PubMed ID: 32776099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of nomograms to accurately predict risk of recurrence for patients with laryngeal squamous cell carcinoma: Cohort study.
    Cui J; Wang L; Tan G; Chen W; He G; Huang H; Chen Z; Yang H; Chen J; Liu G
    Int J Surg; 2020 Apr; 76():163-170. PubMed ID: 32173614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of survival in patients with thin melanoma: results from a multi-institution study.
    Maurichi A; Miceli R; Camerini T; Mariani L; Patuzzo R; Ruggeri R; Gallino G; Tolomio E; Tragni G; Valeri B; Anichini A; Mortarini R; Moglia D; Pellacani G; Bassoli S; Longo C; Quaglino P; Pimpinelli N; Borgognoni L; Bergamaschi D; Harwood C; Zoras O; Santinami M
    J Clin Oncol; 2014 Aug; 32(23):2479-85. PubMed ID: 25002727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy.
    Wang SB; Qi WX; Chen JY; Xu C; Kirova YM; Cao WG; Cai R; Cao L; Yan M; Cai G
    Radiat Oncol; 2019 Jul; 14(1):128. PubMed ID: 31315683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and external validation of a nomogram predicting overall survival after curative resection of colon cancer.
    Wang S; Liu Y; Shi Y; Guan J; Liu M; Wang W
    J Int Med Res; 2021 May; 49(5):3000605211015023. PubMed ID: 33990147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomograms to predict survival outcomes after microwave ablation in elderly patients (>65 years old) with early-stage hepatocellular carcinoma.
    Huang Z; Gu Y; Zhang T; Wu S; Wang X; An C; Huang J
    Int J Hyperthermia; 2020; 37(1):808-818. PubMed ID: 32619374
    [No Abstract]   [Full Text] [Related]  

  • 17. An external validation study of nomograms designed to predict isolated loco-regional and distant endometrial cancer recurrences: how applicable are they?
    Bendifallah S; Canlorbe G; Raimond E; Bazire L; Huguet F; Graesslin O; Rouzier R; Darai E; Ballester M
    Br J Cancer; 2013 Sep; 109(6):1498-503. PubMed ID: 23989946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic nomograms for gastric carcinoma after surgery to assist decision-making for postoperative treatment with chemotherapy cycles <9 or chemotherapy cycles ≥9.
    Li Y; Zhang X
    Front Surg; 2022; 9():916483. PubMed ID: 36090344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal prognostication in retroperitoneal sarcoma survivors: Development and external validation of two dynamic nomograms.
    Callegaro D; Barretta F; Swallow CJ; Strauss DC; Bonvalot S; Honorè C; Stoeckle E; van Coevorden F; Haas R; Rutkowski P; Schrage Y; Fairweather M; Conti L; Vassos N; Gladdy RA; Ng D; van Houdt WJ; Miceli R; Raut CP; Gronchi A
    Eur J Cancer; 2021 Nov; 157():291-300. PubMed ID: 34555648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder.
    Al-Daghmin A; English S; Kauffman EC; Din R; Khan A; Syed JR; Sztorc J; Mehedint D; Sharif M; Shi Y; Wilding G; Guru KA
    BJU Int; 2014 Aug; 114(2):253-60. PubMed ID: 24119175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.